DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

To our immune system, naked RNA is a sign of a viral or bacterial invasion and must be attacked. But our own cells also have ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved ...

Waltham, Massachusetts–based Skyhawk Therapeutics has been collecting collaborations with larger companies in spades since ...